New potential regulators of uterine leiomyomata from DNA arrays: the ionotropic glutamate receptor GluR2.
New potential regulators of uterine leiomyomata from DNA arrays: the ionotropic glutamate receptor GluR2.
复制标题
DNA 阵列中子宫肌瘤的新潜在调节因子:离子型谷氨酸受体 GluR2。
DOI:
10.1016/j.bbrc.2003.09.189
复制
发表时间:
2003
影响因子:
3.1
通讯作者:
Spellacy,WilliamN
中科院分区:
文献类型:
--
作者:
Tsibris,JohnCM;Maas,Stefan;Segars,JamesH;Nicosia,SantoV;Enkemann,StevenA;O'Brien,WilliamF;Spellacy,WilliamN
In the post-Genome era, new concepts emerge about the growth regulation of uterine leiomyomata. Screening of leiomyoma and myometrial tissues with DNA arrays revealed numerous genes up-regulated in leiomyomata that were not known to be expressed in the human uterus. GluR2, a subunit of a ligand-gated cation channel, is up-regulated in leiomyomata relative to myometrium by 15- to 30-fold at the protein and mRNA level and is localized in endothelial cells. GluR2 pre-mRNA in leiomyoma and myometrial tissues is nearly 100% edited at the Q/R site, indicative of low Ca2+permeability of the ion channels. In spontaneous leiomyomata in women or leiomyomata induced in the guinea pig model, there is a likely synergism linking increased production of estradiol and all-trans retinoic acid with up-regulation of nuclear receptor PPARγ and RXRα proteins to support tumor growth. GluR2 might be coupled to this synergism directly or via interleukin-17B, kinesin KIF5 or related genes also up-regulated in leiomyomata. GluR antagonists should be tested as inhibitors of leiomyoma growth.